Schedule 13G ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2021-02-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,408,849
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000208
- Form type
- SC 13G
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Mar 02, 2021
- Reporting period
- Feb 25, 2021
- Description
- Schedule 13G beneficial ownership